Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …
Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …

